Cresset Asset Management, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Cresset Asset Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $819,271 - $961,408	-800 Reduced 9.88%	7,300 $7.67 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $3.27 Million - $3.96 Million	3,700 Added 84.09%	8,100 $8.51 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $361,076 - $397,340	-400 Reduced 8.33%	4,400 $4.23 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $1.09 Million - $1.23 Million	1,400 Added 41.18%	4,800 $4.22 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $171 Million - $208 Million	-246,600 Reduced 98.64%	3,400 $2.8 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $175 Million - $208 Million	250,000 New	250,000 $180 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.